Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. PJP: which is better?

Bottom line

XLV vs PJP: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PJP (Invesco Pharmaceuticals ETF) are quite different portfolios: only about 38% of their top holdings (by weight) are shared.

XLV is cheaper at 0.08% vs 0.58% — a difference of $50 a year per $10,000 invested.

Over five years, PJP returned +9.0% a year vs +8.1% for XLV.

Updated Nov 19, 2026

XLV vs PJP side by side

XLVPJP
TypeETFETF
Fund familySPDR (State Street)Invesco
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.58%
Annual cost per $10k$8$58
10-yr cost on $10k (prospectus)$103$726
Max front loadNoneNone
12b-1 fee0.02%—
1-yr return+14.5%+27.9%
5-yr return (annualized)+8.1%+9.0%
10-yr return (annualized)+9.8%+5.1%
Best quarter+14.5%+18.1%
Worst quarter−12.7%−14.8%
Net assets (fund)$40.6B$472.1M
Number of holdings6533
Portfolio turnover2%36%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVPJPDifference
2025+14.5%+27.9%−13.4%
2024+2.5%+9.7%−7.2%
2023+2.0%−2.2%+4.2%
2022−2.1%−2.0%−0.0%
2021+25.9%+14.5%+11.5%
2020+13.3%+11.2%+2.1%
2019+20.7%+4.7%+16.0%
2018+6.3%−1.7%+8.0%
2017+21.7%+15.3%+6.4%
2016−2.8%−19.3%+16.4%

Source: Fund prospectus bar charts

Holdings overlap

10 of XLV's top 25 holdings also appear in PJP's top 25.

Shared top holdings
HoldingXLVPJP
Eli Lilly & Co16.51%5.02%
Johnson & Johnson10.64%5.18%
AbbVie Inc7.74%5.48%
Merck & Co Inc5.52%5.06%
Amgen Inc3.40%5.33%
Abbott Laboratories2.75%5.67%
Gilead Sciences Inc2.73%4.53%
Pfizer Inc2.39%4.50%
Bristol-Myers Squibb Co2.05%2.94%
Regeneron Pharmaceuticals Inc1.08%3.14%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

PJP top 10

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Merck & Co., Inc. — 5.06%
  7. Eli Lilly and Co. — 5.02%
  8. Corcept Therapeutics Inc. — 4.96%
  9. Gilead Sciences, Inc. — 4.53%
  10. Pfizer Inc. — 4.50%

FAQ

What is the difference between XLV and PJP?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and PJP (Invesco Pharmaceuticals ETF) are quite different portfolios: only about 38% of their top holdings (by weight) are shared. XLV is cheaper at 0.08% vs 0.58% — a difference of $50 a year per $10,000 invested.
Which is cheaper, XLV or PJP?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and PJP?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.